Pharmafile Logo

Beacon consulting

Beacon Consulting is a specialist pharmaceutical consultancy. We help our clients solve difficult commercial problems and maximise the opportunities for their brands by providing actionable, data driven analysis. We focus on using NHS secondary data sources such as Hospital Episode Statistics (HES), QoF and GP prescribing data to add insight to challenges in: estimating market sizes, modelling patient flows through the health care system, describing variation in treatment practice, patient and physician segmentation, profiling and targeting, forecasting and examining healthcare resource usage and costs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Foxacre, Parkland Grove, Farnham, Surrey, GU9 9HA, United Kingdom
+44 (0)1252 758988

 Latest Content from PMHub 

KVA launch the KVA Mediverse, leading the way in VR healthcare comms

Press Releases | March 23, 2022 | KVA

KVA announce their new unique VR offering

Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization

Press Releases | March 22, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, announces the launch of a new consultancy to add to its family of agencies. Nucleus X Consulting consists of...

Top 10 Most Common Participant Comments – Online Advisory Boards

What advisors and participants have to say about the Impetus InSite Platform!

Healthcare services entrepreneur David Rowley joins KVA

Press Releases | March 21, 2022 | KVA

KVA appoints David Rowley to act as advisor to the board

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

Press Releases | March 21, 2022 | OPEN Health

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

Top 10 Ways that Medical Affairs Team Can Leverage the Impetus Insite Platform

New to asynchronous touchpoints? Don’t know where to start? Need help designing an asynchronous event that will engage your stakeholders and give you the insights you’re looking for? In addition...

Digitalizing Self-Care to Empower Patients

Jonathon Carr-Brown, Chief Operating Officer at Healthily, shares how they are redefining the relationship between retailers and over-the-counter pharmaceutical companies with their customers, and how a digitally-enabled Pre-Primary Care Health...

The Price of Drugs – The Cost of LIVING

With increasing drug prices, what is the true cost to society? (Article written 2nd December 2020)

Medical writing that makes a difference

How to write effectively in Pharma (Article written October 2021)